Just under half (48 percent) of respondents acknowledged having experience with cannabis.
Year: 2024
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
“This study suggests that lifetime exposure to cannabis has few persistent effects on mental health and other psychosocial outcomes,” researchers reported.
Chronic pain patients in the survey reported “greater satisfaction” with cannabis and said that it was “more effective” than their prior therapies.
Previous studies have demonstrated that the co-administration of cannabinoids augments the pain-relieving effects of opioids, even when administered at subtherapeutic doses.
Forty-seven percent of respondents reported having authorized cannabis-based therapies to their pediatric patients.
Investigators concluded, “To our knowledge, this is the first longitudinal cohort study … to report an absence of a relationship between cannabis use and risk of AF.”
Researchers “did not find evidence of increases in health service use or incident cases of psychotic disorders over the short-term (17 month) period following cannabis legalization.”
Eighty-eight percent of those surveyed reported that cannabis “reduced their neuropathic pain intensity by more than 30 percent.”